- 商品介绍
- 规格参数
- 包装参数
|
规格 |
|
| Accession Number: | NM_004624 |
| Assay Entry: | Cell-based beta lactamase reporter gene |
| Cell Line: | CHO-K1 |
| Cell State: | Dividing Cells |
| Druggable Target: | GPCRs |
| Gene Symbol: | VPAC1 |
| Population Status: | Single Cell Clone Origin |
| Product Line: | GeneBLAzer® |
| Reporter Gene: | BLA (Beta-Lactamase) |
| System Type: | GeneBLAzer™ |
| Target Entry: | VPAC1 |
| Technique: | FRET |
| Detection Method: | Fluorescent |
|
储存 |
|
|
Contents: K1705 GeneBLAzer® VPAC1-CRE-bla CHO-K1 cells (LiveBLAzer™-FRET B⁄G Loading Kit, Solution D and other materials are required separately; please refer to the protocol). Includes: • GeneBLAzer® VPAC1-CRE-bla CHO-K1 cells • GeneBLAzer® VPAC1-CRE-bla CHO-K1 Assay Protocol • Certificate of Analysis Storage: The GeneBLAzer® VPAC1-CRE-bla CHO-K1 cells are shipped on dry ice and should be stored in liquid nitrogen immediately upon receipt. |
|
描述 |
GeneBLAzer® VPAC1-CRE-bla CHO-K1 cells contain the human Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide receptor 1 (VPAC1) stably integrated into the CellSensor® CRE-bla CHO-K1 cell line. CellSensor® CRE-bla CHO-K1 cells (Cat. no. K1535) contain a beta-lactamase reporter gene under control of the Cyclic AMP Response Element (CRE) response element.
The GeneBLAzer® VPAC1-CRE-bla CHO-K1 cells are functionally validated for Z' and EC50 concentrations of VIP. In addition, GeneBLAzer® VPAC1-CRE-bla CHO-K1 cells have been tested for assay performance under variable conditions. These data are found in the Validation & Assay Performance Summary.
VPAC1 has been implicated in a wide range of disorders, including Parkinson's disease, septic shock, rheumatoid arthritis, multiple sclerosis, Crohn's disease, and autoimmune diabetes. VPAC1-mediated signaling has also been shown to play a role in HIV infection.
For Academic pricing please login or contact us at discoverysciences@invitrogen.com.
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |



微信小程序
7X24小时在线咨询